Breast cancer, Secondary cancers
Results
Phase 4
This study looked at the effect that abemaciclib might have on people’s and their daily lives.
The study was open for people to join between 2020 and 2022. The team published the results in 2025.
Recruitment start: 1 September 2020
Recruitment end: 31 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Dame Lesley Fallowfield
Eli Lilly and Company Limited
Brighton & Sussex Medical School
University of Sussex
Last reviewed: 18 Dec 2025
CRUK internal database number: 17003
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
